Related references
Note: Only part of the references are listed.A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Marnix Lam et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for 90Y imaging and dosimetry optimization: A quantitative study
Nicola Trotta et al.
MEDICAL PHYSICS (2022)
Can Post-Treatment Dosimetry Predict Clinical Outcomes in Segmental Transarterial Radioembolization of Hepatocellular Carcinoma?
C.S. Seldon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory
Wali Badar et al.
BRITISH JOURNAL OF RADIOLOGY (2021)
Experience with regorafenib in the treatment of hepatocellular carcinoma
Alessandro Granito et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)
mRECIST for HCC: Performance and novel refinements
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2020)
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study
Anne-Laure Hermann et al.
RADIOLOGY (2020)
Repeated radioembolization in advanced liver cancer
Max Masthoff et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?
Veronica Moran et al.
EJNMMI PHYSICS (2020)
High versus low dose Stereotactic Body Radiation Therapy for hepatic metastases
Esther N. D. Kok et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2020)
Hepatobiliary Cancers, Version 2.2019 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy
Marilyne Kafrouni et al.
EJNMMI RESEARCH (2019)
Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5cm)
Jing Sun et al.
BMC CANCER (2019)
Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization
Camille Hardy-Abeloos et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
A new homogeneity index definition for evaluation of radiotherapy plans
Lingling Yan et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2019)
Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma
Keith T. Chan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
Eli Sapir et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry
Anand Mahadevan et al.
RADIATION ONCOLOGY (2018)
Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Michael Velec et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT
Paul Haste et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Improved quantitative 90Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling
Yuni K. Dewaraja et al.
MEDICAL PHYSICS (2017)
Correlation between Heterogeneity index (Hi) and Gradient Index (GI) for High Dose Stereotactic Radiotherapy/Radiosurgery (SRT/SRS)
B. Tas et al.
PROCEEDINGS OF THE TURKISH PHYSICAL SOCIETY 32ND INTERNATIONAL PHYSICS CONGRESS (TPS32) (2017)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
Multi-Lesion Cranial SRS VMAT Plan Quality
A. Ballangrud et al.
MEDICAL PHYSICS (2016)
Practical reconstruction protocol for quantitative 90Y bremsstrahlung SPECT/CT
W. Siman et al.
MEDICAL PHYSICS (2016)
90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments
Arthur J. A. T. Braat et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
PET/CT- Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on 99mTc-MAA Imaging and Correlation With Treatment Efficacy
Yoo Sung Song et al.
MEDICINE (2015)
Determination of radiation absorbed dose to primary liver tumors and normal liver tissue using post-radioembolization Y-90 PET
Shyam M. Srinivas et al.
FRONTIERS IN ONCOLOGY (2014)
A dose homogeneity and conformity evaluation between ViewRay and pinnacle-based linear accelerator IMRT treatment plans
Daniel L. Saenz et al.
JOURNAL OF MEDICAL PHYSICS (2014)
Safety of Repeated Yttrium-90 Radioembolization
Marnix G. E. H. Lam et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Tc-99m-Macroaggregated Albumin Poorly Predicts the Intrahepatic Distribution of Y-90 Resin Microspheres in Hepatic Radioembolization
Maurits Wondergem et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Comparison of Positron Emission Tomography and Bremsstrahlung Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization for Large Hepatocellular Carcinomas or Associated Portal Vein Thrombosis
Siddharth A. Padia et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Homogeneity Index: An objective tool for assessment of conformal radiation treatments
Tejinder Kataria et al.
JOURNAL OF MEDICAL PHYSICS (2012)
State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83)
V. Gregoire et al.
CANCER RADIOTHERAPIE (2011)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival
Philip Hilgard et al.
HEPATOLOGY (2010)
QUANTITATIVE ANALYSES OF NORMAL TISSUE EFFECTS IN THE CLINIC (QUANTEC): AN INTRODUCTION TO THE SCIENTIFIC ISSUES
Soren M. Bentzen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations
Lidia Strigari et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Radioembolization of Liver Tumors With Yttrium-90 Microspheres
Hojjat Ahmadzadehfar et al.
SEMINARS IN NUCLEAR MEDICINE (2010)
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium
Andrew Kennedy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Conformity index:: A review
L Feuvret et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Share Paper
